Expression of Somatostatin Receptor Subtype 1–5 Genes in Human Pancreatic Cancer (Q74257289)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

title

Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

Expression of Somatostatin Receptor Subtype 1–5 Genes in Human Pancreatic Cancer (English)

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

10 December 2024

1 reference

W. E. Fisher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9486819

10 December 2024

T. A. Doran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9486819

10 December 2024

P. Muscarella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9486819

10 December 2024

L. G. Boros

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9486819

10 December 2024

E. C. Ellison

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9486819

10 December 2024

W. J. Schirmer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9486819

10 December 2024

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

18 February 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9486819

full work available at URL

10 December 2024

published in

Journal of the National Cancer Institute

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

322-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

Effects of chronic administration of somatostatin on rat exocrine pancreas

9 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide

10 December 2024

3

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney

10 December 2024

4

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Cloning and characterization of a fourth human somatostatin receptor

10 December 2024

6

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype

10 December 2024

7

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

10 December 2024

8

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Hormonal control of pancreatic cancer growth

10 December 2024

9

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

10 December 2024

10

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.

10 December 2024

12

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice

10 December 2024

13

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts

10 December 2024

14

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

10 December 2024

15

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study

10 December 2024

16

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research

10 December 2024

17

1 reference

https://api.crossref.org/works/10.1093/JNCI/90.4.322

10 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9486819 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference